Science news

Read the latest science news headlines and see what’s new in science. WeeklyReviewer brings you top science headlines from leading industry news.

Science is a rapidly changing and growing platform. Make sure you are always up to date on what’s new in science!

Caliway Closes Oversubscribed Capital Raise and Secures Over $100M to Advance CBL-514 Pivotal Phase 3 Study in Subcutaneous Fat Reduction

TAIPEI, Dec. 16, 2023 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) announced that it has closed an oversubscribed capital raise, securing over $100M by issuing 8...

Global Latent TB Testing Market Analysis Report 2023-2029 Featuring QIAGEN, Sanofi, Abbott, Serum Institute, F. Hoffmann-La Roche, Bio-Rad Laboratories, PerkinElmer, BioMerieux, BD and Co,...

DUBLIN, Dec. 15, 2023 /PRNewswire/ -- The "Global Latent TB Testing Market (2023 Edition): Analysis By Test Type (TST, IGRA), End User, By Region, By Country:...

NATSO, SIGMA Statement on Department of Treasury Guidance for Implementation of the Sustainable Aviation Fuel (SAF) Tax Credit

ALEXANDRIA, Va., Dec. 15, 2023 /PRNewswire/ -- NATSO and SIGMA: America's Leading Fuel Marketers issued the following statement today in response to the Department...

World Economic Forum recognises Tata Power subsidiary TPRMG as people-positive accelerator of clean energy adoption in rural India

NEW DELHI, Dec. 15, 2023 /CNW/ -- TP Renewable Microgrid (TPRMG), a wholly owned subsidiary of Tata Power- one of India's largest integrated power companies,...

White Goods Coatings Market to Reach $10.2 Billion, Globally, by 2032 at 6.2% CAGR: Allied Market Research

The global white goods coatings market is experiencing notable growth due to several factors such as expansion of the white goods market and surge...

BlueFin Achieves ISO 9001 and ISO 45001 Certification

NEW IBERIA, La., Dec. 14, 2023 /PRNewswire/ -- BlueFin, a 100% employee-owned, GATE Energy company, is proud to announce that they have successfully achieved...

Imlifidase met primary endpoint in 16-HMedIdes-12 phase 2 trial in patients with AMR following kidney transplantation

Statistically significant reduction in donor-specific antibodies (DSAs) observed among imlifidase patients within five days of treatment as compared to standard of care LUND, Sweden, Dec....

Kira Pharmaceuticals Presents Positive Results of KP104 Phase 2 Study in Complement-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) at the 2023 ASH Annual Meeting

An Interim analysis of 18 patients, completing 24/25 weeks of treatment in a phase 2 study in complement-naïve PNH patients demonstrates that KP104 is safe,...

Mission Therapeutics announces US FDA approval to initiate Phase II clinical trial of its lead asset MTX652 in Acute Kidney Injury

Mission gains clearance from US FDA for Phase II trial of MTX562 after it receives official approval of its Investigational New Drug (IND) applicationPhase...
1...545556...429Page 55 of 429

Latest articles